TWST – twist bioscience corporation (US:NASDAQ)

News

Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com